Abstract:Objective: Dysregulation of the immune system plays a vital role in the pathological process of vascular dementia, and this study aims to spot critical biomarkers and immune infiltrations in vascular dementia employing a bioinformatics approach. Methods: We acquired gene expression profiles from the Gene Expression Database. The gene expression data were analyzed using the bioinformatics method to identify candidate immune-related central genes for the diagnosis of vascular dementia. and the diagnostic value of nomograms and Receiver Operating Characteristic (ROC) curves were evaluated. We also examined the role of the VaD hub genes. Using the database and potential therapeutic drugs, we predicted the miRNA and lncRNA controlling the Hub genes. Immune cell infiltration was initiated to examine immune cell dysregulation in vascular dementia. Results: 1321 immune genes were included in the combined immune dataset, and 2816 DEGs were examined in GSE122063. Twenty potential genes were found using differential gene analysis and co-expression network analysis. PPI network design and functional enrichment analysis were also done using the immune system as the main subject. To create the nomogram for evaluating the diagnostic value, four potential core genes were chosen by machine learning. All four putative center genes and nomograms have a solid diagnostic value (AUC ranged from 0.81 to 0.92). Their high confidence level became unquestionable by validating each of the four biomarkers using a different dataset. According to GeneMANIA and GSEA enrichment investigations, the pathophysiology of VaD is strongly related to inflammatory responses, drug reactions, and central nervous system degeneration. The data and Hub genes were used to construct a ceRNA network that includes three miRNAs, 90 lncRNA, and potential VaD therapeutics. Immune cells with varying dysregulation were also found. Conclusion: Using bioinformatic techniques, our research identified four immune-related candidate core genes (HMOX1, EBI3, CYBB, and CCR5). Our study confirms the role of these Hub genes in the onset and progression of VaD at the level of immune infiltration. It predicts potential RNA regulatory pathways control VaD progression, which may provide ideas for treating clinical disease.

Identification and Analysis of Toll Like Receptor 4 (tlr4) Level Changes in Vascular Dementia Patients Related Type 2 Diabetes Mellitus

Characteristics of the Peripheral T Cell Immune Response of Patients at Different Stages of Vascular Cognitive Impairment.

Study on Expression of Toll-like Receptor 4 in Peripheral Blood Mononuclear Cells from Patients with Alzheimer Disease and Vascular Dementia

Identification of TLR2 as a Key Target in Neuroinflammation in Vascular Dementia

VEGF Levels in Plasma in Relation to Metabolic Control, Inflammation, and Microvascular Complications in Type-2 Diabetes A Cohort Study

Identification of toll-like receptor 2 as a key regulator of neuronal apoptosis in vascular dementia by bioinformatics analysis and experimental validation

Vascular Cognitive Impairment Caused by Cerebral Small Vessel Disease Is Associated with the TLR4 in the Hippocampus

Increased Expressions of TLR2 and TLR4 on Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease

Effect of cerebral small vessel disease on cognitive function and TLR4 expression in hippocampus

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease

Exploring the Relationship Between Lymphatic System Damage and Insulin Resistance in T2DM Based on Vascular Periadventitial Tensor Analysis and Triglyceride-Glucose Index

Impaired toll-like receptor signalling in peripheral B cells from newly diagnosed type-2 diabetic subjects

Relationship Between Toll-like Receptor 4 Single Nucleotide Polymorphisms and Alzheimer Disease in Chinese Han Population

T Lymphocyte Subsets in Type 2 Diabetes and Its Macrovascular Complications

Association Between Toll-Like Receptor 4 and Occurrence of Type 2 Diabetes Mellitus Susceptible to Pulmonary Tuberculosis in Northeast China

Identification of immune-associated genes in vascular dementia by integrated bioinformatics and inflammatory infiltrates

Regulation by 1, 25-Dihydroxy-vitamin D3 on Altered Tlrs Expression and Response to Ligands of Monocyte from Autoimmune Diabetes

Toll-Like Receptor 4 in Bone Marrow-Derived Cells Contributes to the Progression of Diabetic Retinopathy

Association between serum levels of inflammatory cytokines toll-like receptor 4 and lipopolysaccharide receptor 14 and occurrence of type 2 diabetes mellitus complicated with pulmonary tuberculosis

TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment

Dysfunctional monocytic toll-like receptor 4 signaling pathway and cognitive deficits in chronic schizophrenia patients with tardive dyskinesia